The Cancer Prevention and Research Institute of Texas awarded a relocation grant to Hummingbird Bioscience
On Jun. 4, 2019, the Cancer Prevention and Research Institute of Texas (CPRIT) awarded a $13 million relocation…
-
-
Penn received a $12 million grant to study the connection between cellular therapies and new methods of radiation therapy
On Jun. 3, 2019, the University of Pennsylvania (Penn) announced it had received a $12 million grant from…
-
FUJIFILM opened Life Science Strategic Business Office in Cambridge, Massachusetts
On May 30, 2019, FUJIFILM opened a Life Science Strategic Business Office in Cambridge, Massachusetts to create a…
-
The Richard N Merkin Institute for Translational Research was founded at CalTech
On May 30, 2019, The Richard N. Merkin Institute for Translational Research was founded at CalTech. Merkin, who…
-
The National Cancer Institute Annual Report to the Nation found cancer death rates continue to drop
On May 30, 2019, a report from the nation’s leading cancer organizations found that Americans’ risk of dying…
-
Amgen announced the launch of Amgen Community Oncology Research Collaborators
On May 28, 2019, Amgen, along with leading community oncology networks, announced the launch of Amgen Community Oncology…
-
At $2M, priciest ever medicine treats fatal genetic disease
On May 24, 2019, U.S. regulators have approved the most expensive medicine ever, for a rare disorder that destroys…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Neurology
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) authorized marketing of a diagnostic test to…
-
The USDA announced a new vision for animal genomics
On May 16, 2019, a U.S. Department of Agriculture (USDA) blueprint, published in “Frontiers and Genetics,” will serve…
-
Chembio Diagnostics announced approval of Dengue point-of-care test by Brazilis Health Regulatory Agency
On May 7, 2019, Chembio Diagnostics announced the approval of its DPP Dengue System by Agência Nacional de…
-
U.S. FDA Approved Arctic® Fuji Apple
On May 2, 2019, the U.S. Food and Drug Authority (FDA) announced it had completed its voluntary review…
-
Massachusetts General Hospital received $200 million to advance research into complex diseases
On Apr. 25, 2019, Massachusetts General Hospital (MGH) announced it had received the largest gift in the hospital’s…
-
UGA researchers discovered a vaccine for Crimean-Congo Hemorrhagic Fever (CCHF) virus
On Apr. 25, 2019, researchers at the University of Georgia announced they had successfully discovered a single-dose vaccine…
-
GSK invested $100 million to expand long-term vaccine manufacturing capabilities in Hamilton
On Apr. 24, 2019, GSK announced $100 million of new investment in its manufacturing site in Hamilton, Montana…
-
St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease
On Apr. 18, 2019, St. Jude announced a cure for SCID-X1, commonly known as bubble boy disease. By…
-
Sinovac announced positive results from phase III trial of a Sabin strain-based inactivated Polio vaccine (sIPV) were published
On Apr. 16, 2019, Sinovac Biotech announced that the positive results from the Company’s Phase III clinical study…
-
Chembio Diagnostics received approval of Zika, Dengue and Chikungunya point-of-care multiplex test by Brazil’s Health Regulatory Agency
On Apr. 9, 2019, Chembio Diagnostics announced the approval of its DPP Zika/Dengue/Chikungunya System by Agencia Nacional de…
-
Amgen announced FDA approval of EVENITY for the treatment of osteoporosis
On Apr. 9 2019, Amgen announced U.S. Food and Drug Administration (FDA) approval of EVENITY (romosozumab-aqqg) for the…
-
The Priestley Medal was awarded to K. Barry Sharpless
On Mar. 31, 2019, the American Chemical Society awarded the Priestley Medal to K. Barry Sharpless “to recognize…
-
The only FDA approved IV antimalarial in the US, IV quinidine, was discontinued
In Mar. 29, 2019, the Centers for Disease Control and Prevention (CDC) issued new guidance to clinicians for…
-
Masonic Cancer Center researcher Dr. Liang Liu received skin cancer research grant
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a $100,000 two year…
-
Biotechnology | Cloning | CRISPR | Disease | Genomics | Medicine | Therapeutics
Moratorium on heritable genome editing published in “Nature”
On Mar. 13, 2019, Nature published a call for a global moratorium on heritable human genome editing signed by…
-
The University of Alabama’s newest cancer-killing cyclotron was installed
On Mar. 5, 2019, Emma, the 90-ton cyclotron that is the centerpiece of the new proton therapy initiative at…
-
Scientists described the first-ever successful in situ collection of a bacteria that eats and breathes electricity
On Mar. 5, 2019, scientists at Washington State University (WSU) described the first-ever successful in situ collection of…
-
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
-
The Tyrosinemia Society Was founded
On Feb. 25, 2019, the Tyrosinemia Society (TS, Inc.) was founded by Dr. Elizabeth Barnby, a researcher and…
-
ICON acquired MolecularMD
On Feb. 21, 2019, ICON announced that it had acquired MolecularMD, a molecular diagnostic specialty laboratory that enables…
-
Biotechnology | CDC | Vaccine
CDC published ACIP recommendations for use of hepatitis A vaccine for persons experiencing homelessness
On Feb. 15, 2019, the U.S. Centers for Disease Control and Prevention (CDC) published ACIP recommendations for use….
-
CDC released the 2019 US recommended immunization schedules for children/adolescents as well as for adults
On Feb. 8, 2019, the U.S. Centers for Disease Control and Prevention (CDC) released the 2019 U.S. recommended…
-
Perlmutter Cancer Center earned Comprehensive status from the National Cancer Institute
On Feb. 6, 2019, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health was designated a Comprehensive…
